应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
KRRO Korro Bio, Inc.
休市中 10-04 16:00:00 EDT
33.59
+2.29
+7.32%
盘后
33.50
-0.09
-0.27%
19:57 EDT
最高
34.00
最低
30.72
成交量
12.40万
今开
31.54
昨收
31.30
日振幅
10.48%
总市值
3.12亿
流通市值
1.49亿
总股本
929.88万
成交额
409.93万
换手率
2.79%
流通股本
443.61万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Korro Bio, Inc.盘中异动 股价大涨5.21%
市场透视 · 10-05 00:44
Korro Bio, Inc.盘中异动 股价大涨5.21%
Korro Bio, Inc.盘中异动 早盘股价大跌5.06%
市场透视 · 10-03 23:02
Korro Bio, Inc.盘中异动 早盘股价大跌5.06%
Korro Bio, Inc.盘中异动 临近收盘快速跳水5.53%报32.60美元
市场透视 · 10-01
Korro Bio, Inc.盘中异动 临近收盘快速跳水5.53%报32.60美元
Korro Bio, Inc.盘中异动 股价大涨5.59%
市场透视 · 09-27
Korro Bio, Inc.盘中异动 股价大涨5.59%
Korro Bio, Inc.盘中异动 股价大跌5.51%
市场透视 · 09-20
Korro Bio, Inc.盘中异动 股价大跌5.51%
Korro Bio, Inc.盘中异动 快速拉升5.95%
市场透视 · 09-19
Korro Bio, Inc.盘中异动 快速拉升5.95%
Korro Bio Inc 预计每股亏损 2.39 美元 - 财报前瞻
Reuters · 08-06
Korro Bio Inc 预计每股亏损 2.39 美元 - 财报前瞻
HC Wainwright & Co.:维持Korro Bio(KRRO.US)评级,由买入调整至买入评级, 目标价由115.
智通财经 · 05-15
HC Wainwright & Co.:维持Korro Bio(KRRO.US)评级,由买入调整至买入评级, 目标价由115.
Korro Bio Inc 预计每股亏损 2.51 美元 - 财报前瞻
Reuters · 05-08
Korro Bio Inc 预计每股亏损 2.51 美元 - 财报前瞻
加载更多
公司概况
公司名称:
Korro Bio, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Korro Bio, Inc.是一家特拉华州公司。Korro Bio是一家生物制药公司,其使命是发现、开发和商业化一种基于编辑RNA的新型基因药物,从而能够治疗罕见和高度流行的疾病。Korro Bio正在开发一系列差异化程序,旨在利用人体的自然RNA编辑过程,实现精确而短暂的单碱基编辑。
发行价格:
--
{"stockData":{"symbol":"KRRO","market":"US","secType":"STK","nameCN":"Korro Bio, Inc.","latestPrice":33.59,"timestamp":1728072000000,"preClose":31.3,"halted":0,"volume":123953,"hourTrading":{"tag":"盘后","latestPrice":33.5,"preClose":33.59,"latestTime":"19:57 EDT","volume":93566,"amount":3221865.24,"timestamp":1728086247136},"delay":0,"floatShares":4436097,"shares":9298815,"eps":-15.113954,"marketStatus":"休市中","marketStatusCode":7,"change":2.29,"latestTime":"10-04 16:00:00 EDT","open":31.54,"high":34,"low":30.719,"amount":4099253.38159,"amplitude":0.104824,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-15.113954,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1728288000000},"adr":0,"listingDate":1570075200000,"adjPreClose":31.3,"preHourTrading":{"tag":"盘前","latestPrice":31.3,"preClose":31.3,"latestTime":"09:21 EDT","volume":300,"amount":9390,"timestamp":1728048067886},"postHourTrading":{"tag":"盘后","latestPrice":33.5,"preClose":33.59,"latestTime":"19:57 EDT","volume":93566,"amount":3221865.24,"timestamp":1728086247136},"volumeRatio":2.521518816360505},"requestUrl":"/m/hq/s/KRRO","defaultTab":"news","newsList":[{"id":"2473967835","title":"Korro Bio, Inc.盘中异动 股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473967835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473967835?lang=zh_cn&edition=full","pubTime":"2024-10-05 00:44","pubTimestamp":1728060246,"startTime":"0","endTime":"0","summary":"北京时间2024年10月05日00时44分,Korro Bio, Inc.股票出现波动,股价大幅拉升5.21%。Korro Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.25%。Korro Bio, Inc.公司简介:Korro Bio Inc 是一家生物制药公司,其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物,使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241005004406ab67c14f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241005004406ab67c14f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2472617414","title":"Korro Bio, Inc.盘中异动 早盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472617414","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472617414?lang=zh_cn&edition=full","pubTime":"2024-10-03 23:02","pubTimestamp":1727967762,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日23时02分,Korro Bio, Inc.股票出现异动,股价大幅下挫5.06%。Korro Bio, Inc.股票所在的生物技术行业中,整体跌幅为1.08%。Korro Bio, Inc.公司简介:Korro Bio Inc 是一家生物制药公司,其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物,使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003230242ab679b16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003230242ab679b16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2472355917","title":"Korro Bio, Inc.盘中异动 临近收盘快速跳水5.53%报32.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472355917","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472355917?lang=zh_cn&edition=full","pubTime":"2024-10-01 03:47","pubTimestamp":1727725657,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日03时47分,Korro Bio, Inc.股票出现波动,股价急速下跌5.53%。截至发稿,该股报32.60美元/股,成交量5.9217万股,换手率0.64%,振幅6.78%。Korro Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.02%。Korro Bio, Inc.公司简介:Korro Bio Inc 是一家生物制药公司,其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物,使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001034738a1ddbef4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001034738a1ddbef4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2470086777","title":"Korro Bio, Inc.盘中异动 股价大涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470086777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470086777?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:43","pubTimestamp":1727444592,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日21时43分,Korro Bio, Inc.股票出现波动,股价急速拉升5.59%。Korro Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Korro Bio, Inc.公司简介:Korro Bio Inc 是一家生物制药公司,其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物,使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409272143129719d1d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409272143129719d1d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2468678213","title":"Korro Bio, Inc.盘中异动 股价大跌5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468678213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468678213?lang=zh_cn&edition=full","pubTime":"2024-09-20 23:34","pubTimestamp":1726846495,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日23时34分,Korro Bio, Inc.股票出现异动,股价大幅下跌5.51%。Korro Bio, Inc.股票所在的生物技术行业中,整体跌幅为2.25%。Korro Bio, Inc.公司简介:Korro Bio Inc 是一家生物制药公司,其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物,使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409202334559719c0aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409202334559719c0aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2468577965","title":"Korro Bio, Inc.盘中异动 快速拉升5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468577965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468577965?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:46","pubTimestamp":1726753591,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时46分,Korro Bio, Inc.股票出现波动,股价快速上涨5.95%。Korro Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.44%。Korro Bio, Inc.公司简介:Korro Bio Inc 是一家生物制药公司,其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物,使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919214631a1db3216&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919214631a1db3216&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2457028329","title":"Korro Bio Inc 预计每股亏损 2.39 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457028329","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457028329?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:40","pubTimestamp":1722951617,"startTime":"0","endTime":"0","summary":" * Korro Bio Inc 将于8月8日公布截至2024年6月30日的财报() 预计该公司的季度收入将保持不变。* * LSEG 的分析师平均预计 Korro Bio Inc 每股亏损 2.39 美元。* 目前,分析师对该公司股票的平均评级为 \"买入\",建议分类为 4 个 \"强烈买入 \"或 \"买入\",没有 \"持有\",也没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Korro Bio Inc 的 12 个月目标价中值为 112.50 美元,高于其上一次收盘价 38.21 美元。8月6日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Korro Bio Inc 预计每股亏损 2.39 美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO"],"gpt_icon":0},{"id":"2435651203","title":"HC Wainwright & Co.:维持Korro Bio(KRRO.US)评级,由买入调整至买入评级, 目标价由115.","url":"https://stock-news.laohu8.com/highlight/detail?id=2435651203","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435651203?lang=zh_cn&edition=full","pubTime":"2024-05-15 23:10","pubTimestamp":1715785852,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2433150742","title":"Korro Bio Inc 预计每股亏损 2.51 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433150742","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433150742?lang=zh_cn&edition=full","pubTime":"2024-05-08 19:33","pubTimestamp":1715168028,"startTime":"0","endTime":"0","summary":" * Korro Bio Inc 将于5月10日公布截至0001年1月1日的财报。* * LSEG 的分析师平均预计 Korro Bio Inc 每股亏损 2.51 美元。* 华尔街对 Korro Bio Inc 的 12 个月目标价中位数为 117.50 美元,高于其上一次收盘价 54.01 美元。5月8日 - 上一季度业绩。除非另有说明,所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://korrobio.com","stockEarnings":[{"period":"1week","weight":-0.0267},{"period":"1month","weight":-0.208},{"period":"3month","weight":-0.0805},{"period":"6month","weight":-0.5033},{"period":"1year","weight":1.4881},{"period":"ytd","weight":-0.2992}],"compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":0.04},{"period":"3month","weight":0.0331},{"period":"6month","weight":0.1052},{"period":"1year","weight":0.3498},{"period":"ytd","weight":0.2055}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Korro Bio, Inc.是一家特拉华州公司。Korro Bio是一家生物制药公司,其使命是发现、开发和商业化一种基于编辑RNA的新型基因药物,从而能够治疗罕见和高度流行的疾病。Korro Bio正在开发一系列差异化程序,旨在利用人体的自然RNA编辑过程,实现精确而短暂的单碱基编辑。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.151165},{"month":2,"riseRate":0.2,"avgChangeRate":-0.240548},{"month":3,"riseRate":0.2,"avgChangeRate":-0.127032},{"month":4,"riseRate":0.2,"avgChangeRate":-0.169505},{"month":5,"riseRate":0.2,"avgChangeRate":-0.085733},{"month":6,"riseRate":0.6,"avgChangeRate":0.073242},{"month":7,"riseRate":0.6,"avgChangeRate":0.186094},{"month":8,"riseRate":0.4,"avgChangeRate":-0.032825},{"month":9,"riseRate":0,"avgChangeRate":-0.150423},{"month":10,"riseRate":0.4,"avgChangeRate":-0.070255},{"month":11,"riseRate":0.8,"avgChangeRate":0.611852},{"month":12,"riseRate":1,"avgChangeRate":0.232406}],"exchange":"NASDAQ","name":"Korro Bio, Inc.","nameEN":"Korro Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Korro Bio, Inc.(KRRO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Korro Bio, Inc.(KRRO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Korro Bio, Inc.,KRRO,Korro Bio, Inc.股票,Korro Bio, Inc.股票老虎,Korro Bio, Inc.股票老虎国际,Korro Bio, Inc.行情,Korro Bio, Inc.股票行情,Korro Bio, Inc.股价,Korro Bio, Inc.股市,Korro Bio, Inc.股票价格,Korro Bio, Inc.股票交易,Korro Bio, Inc.股票购买,Korro Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Korro Bio, Inc.(KRRO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Korro Bio, Inc.(KRRO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}